Remote ischemic preconditioning in myocardial protection in hemodialysis patients

Figures & data

Table 1 Characterization of samples according to the studied groups

Studied Groups	Groups		p*
	Control	Intervention
Gender, n (%)
Female	9.0 (40.9)	8.0 (34.8)	0.672*
Male	13.0 (59.1)	15.0 (65.2)
Kt/V	1.5 (1.1–1.5)	1.5 (1.1–1.6)	0.846**
Hemoglobin, g/dL	10.6 (10.4–11.5)	11.1 (10.8–11.6)	0.190**
Albumin, g/dL	3.8 (3.6–4.0)	4.0 (3.9–4.1)	0.010**
Ferritin, ug/L	560.0 (364.9–563.5)	375.0 (278.1–391.7)	0.076**

Notes: Confidence interval of 95% shown in brackets;

* chi-square;

** Mann–Whitney test.

Table 2 Point estimation (interval estimation) of troponin concentration according to the moments in control and intervention groups

cTn	Control			Intervention
	Pre	Post	p*	Pre	Post	p*
Troponin 1	0.010 (0.006–0.016)	0.009 (0.006–0.023)	0.631	0.007 (0.006–0.012)	0.007 (0.006–0.011)	0.152
Troponin 2	0.010 (0.006–0.014)	0.011 (0.006–0.018)	0.634	0.009 (0.006–0.017)	0.006 (0.006–0.014)	0.987
Troponin 3	0.011 (0.006–0.018)	0.013 (0.007–0.027)	0.024	0.007 (0.006–0.018)	0.006 (0.006–0.009)	0.136

Notes: Values expressed in median (confidence interval of 95%);

* Wilcoxon test.

Table 3 Point estimation of concentration variation of urea, troponin and urea reduction ratio between groups

Markers	Groups		p**
	Control	Intervention
Urea*	63.50 (36.86–89.35)	75.75 (35.86–104.52)	0.672
Troponin*	–0.001 (–0.0064–0.0021)	0.001 (–0.0014–0.0014)	0.441
Urea reduction ratio*	–0.650 (–8.074–11.427)	4.500 (–8.090–13.901)	0.503

Notes: Values expressed in median (confidence interval of 95%);

* variation between the first and last collection;

** Wilcoxon test.